RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance on Two Cardiac-Related Patent Applications

11/18/2011 9:51:47 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) announced today that the Company has been notified that two cardiac-related patents will be allowed in Australia and Mexico.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• RegeneRx Biopharmaceuticals, Inc.

• Biotech/Pharma - Patent News